The problems encountered by expedition doctors are diverse and can be immensely challenging. They range from decompression sickness to highaltitude cerebral oedema, and from immersion hypothermia to the management of multiple trauma patients without any medical kit. Advice was presented on how to deal with these problems and many more. Our understanding of the pathophysiology of high-altitude cerebral oedema is still incomplete, but there is hope that work currently under way may identify genes that predispose individuals to altitude illness. There is active debate among experts about what factors limit exercise performance at high altitude. The accepted explanation has been that a failure of bulk oxygen delivery to the tissues is the limiting factor, but it has been proposed that alternatives such as inefficient microvascular flow or alterations in mitochondrial function may be more important.
Get full access to this article
View all access options for this article.
References
1.
JohnsonCAndersonSDallimoreJOxford handbook of expedition and wilderness medicine. Oxford: Oxford University Press; 2008.
2.
VillarRN.Casualties on Everest – an evacuation problem. Injury1986; 17:138–42.
3.
DorwardDAThompsonAABaillieJKChange in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness. Respir Med2007; 101:587–94.
4.
HackettPHYarnellPRHillRHigh-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA1998; 280:1920–5.
5.
WindsorJS.Voices in the air. BMJ 2008; 337:a2667.
6.
BaisdenDLBevenGECampbellMRHuman health and performance for long-duration spaceflight. Aviat Space Environ Med2008; 79:629–35.
7.
GrocottMRichardsonAMontgomeryHCaudwell Xtreme Everest: a field study of human adaptation to hypoxia. Crit Care2007; 11:151.
8.
BartschPMaggioriniMRitterMPrevention of high-altitude pulmonary edema by nifedipine. N Engl J Med1991; 325:1284–9.
9.
GrissomCKRoachRCSarnquistFHAcetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med1992; 116:461–5.
10.
MaggioriniMHPBrunner-La RoccaPethSBoth tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med2006; 145:497–506.
11.
HackettPHRoachRCWoodRADexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med1988; 59:950–4.
12.
WilsonMHNewmanSImrayCH.The cerebral effects of ascent to high altitudes. Lancet Neurol2009; 8:175–91.
13.
BaillieJKSimpsonA. Interactive altitude physiology &medicine calculators. 2006. Available from: http://www.altitude.org/calculators/oxygencalculator/oxygencalculator.htm
14.
LawrieAWatermanESouthwoodMEvidence of a role for osteoprotegerin in the pathogenesis of pulmonary arterial hypertension. Am J Pathol2008; 172:256–64.
15.
ThompsonAABaillieJKToshnerMPericardial effusions in healthy lowlanders after acute ascent to high altitude. Heart2006; 92:539–40.
16.
Stray-GundersenJChapmanRFLevineBD.‘Living high-training low’ altitude training improves sea level performance in male and female elite runners. J Appl Physiol2001; 91:1113–20.
17.
FavretFExerciseRichalet JP.and hypoxia: the role of the autonomic nervous system. Respir Physiol Neurobiol2007; 158:280–6.
18.
MooreR.Heroes, villains and velodromes: Chris Hoy and Britain’s track cycling revolution. London: HarperSport; 2008.
19.
SuttonJRReevesJTWagnerPDOperation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol1988; 64:1309–21.
20.
NiemannSMutations in SDHC cause autosomal dominant paragangliomaMüller U.type3.Nat Genet2000; 26:268–70.
21.
GrocottMPWMartinDSLevettDZHArterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med2009; 360:140–9.
22.
RileyRLCournandA.Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. J Appl Physiol1949; 1:825–47.
23.
WagnerPDGaleGEMoonREPulmonary gas exchange in humans exercising at sea level and simulated altitude. J Appl Physiol1986; 61:260–70.
24.
WagnerPDWestJB.Effects of diffusion impairment on O2 and CO2 time courses in pulmonary capillaries. J Appl Physiol1972; 33:62–71.
25.
AustinD.Gammow bag for acute mountain sickness. Lancet1998; 351:1815.
26.
GoldenFSHerveyGRTiptonMJ.Circum-rescue collapse: collapse, sometimes fatal, associated with rescue of immersion victims. J R Nav Med Serv1991; 77:139–49.
27.
FirthPGZhengHWindsorJSSutherlandAI Mortality on Mount Everest, 1921–2006: descriptive study. BMJ 2008; 337:a2654.
28.
SutherlandAI.Why are so many people dying on Everest?BMJ2006; 333:452.
